Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A ROTH

Showing results (491-500 of 508) with videos related to

Pageof 51
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trialsS M Overholt, T J Liu, D L Taylor, et al.
Cancer Research|July 23, 1999
Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growthP M Mohan, S K Chintala, S Mohanam, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 26, 2006
Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcomeP R Rohatgi, A M Correa, S G Swisher, et al.
Cancer|July 24, 2001
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junctionJ A Ajani, R Komaki, J B Putnam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell linesS S Lakka, R Rajagopal, M K Rajan, et al.
Clinical Pharmacology and Therapeutics|July 24, 2014
Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancerX Pu, L Wang, J Y Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Annals of Internal Medicine|July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymomaD M Shin, G L Walsh, R Komaki, et al.
The British Journal of Surgery|June 7, 2021
Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinomaN Zhou, K G Mitchell, E M Corsini, et al.
Molecular Medicine (Cambridge, Mass.)|July 27, 2001
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapyA M Mhashilkar, R D Schrock, M Hindi, et al.
Pageof 51

Showing results (491-500 of 508) with videos related to

Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trialsS M Overholt, T J Liu, D L Taylor, et al.
Cancer Research|July 23, 1999
Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growthP M Mohan, S K Chintala, S Mohanam, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 26, 2006
Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcomeP R Rohatgi, A M Correa, S G Swisher, et al.
Cancer|July 24, 2001
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junctionJ A Ajani, R Komaki, J B Putnam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell linesS S Lakka, R Rajagopal, M K Rajan, et al.
Clinical Pharmacology and Therapeutics|July 24, 2014
Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancerX Pu, L Wang, J Y Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Annals of Internal Medicine|July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymomaD M Shin, G L Walsh, R Komaki, et al.
The British Journal of Surgery|June 7, 2021
Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinomaN Zhou, K G Mitchell, E M Corsini, et al.
Molecular Medicine (Cambridge, Mass.)|July 27, 2001
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapyA M Mhashilkar, R D Schrock, M Hindi, et al.
Pageof 51